Quoin Pharmaceuticals (QNRX) Short Interest Ratio & Short Volume

Short interest is the volume of Quoin Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 868,800 shares of QNRX short. 17.87% of Quoin Pharmaceuticals' shares are currently sold short. Learn More on Quoin Pharmaceuticals' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 17.87% of Quoin Pharmaceuticals' floating shares are currently sold short.

Quoin Pharmaceuticals saw a decrease in short interest during the month of March. As of March 15th, there was short interest totaling 868,800 shares, a decrease of 67.6% from the previous total of 2,680,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

17.87% of Quoin Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Quoin Pharmaceuticals: Check-Cap Ltd. (3.49%), Nuwellis, Inc. (4.08%), Autonomix Medical, Inc. (3.26%), Sintx Technologies, Inc. (2.43%), Carmell Co. (0.60%), NanoVibronix, Inc. (4.89%), Heart Test Laboratories, Inc. (3.28%), Tenon Medical, Inc. (16.51%), GlucoTrack, Inc. (2.79%), Bone Biologics Co. (14.34%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

Short selling QNRX is an investing strategy that aims to generate trading profit from Quoin Pharmaceuticals as its price is falling. QNRX shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Quoin Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of QNRX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including QNRX, twice per month. The most recent reporting period available is March, 15 2025.